tom beer, md, describes use of dna repair markers when determining treatment of prostate cancer
Published 4 years ago • 53 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
2:09
andrew armstrong, md, on determining treatment of prostate cancer with dna repair markers
-
5:38
germline genetic testing & prostate cancer | 2019 pcri conference excerpt, tomasz beer, md
-
0:42
tom beer, md, on impressions of the card study investigating cabazitaxel in mcrpc patients
-
0:56
tomasz m. beer, md, on how to avoid under-diagnosing and over-diagnosing prostate cancer
-
1:30
why tom chose halo diagnostics' prostate cancer treatment
-
1:46
dr. tomasz m. beer on brca gene defects in advanced prostate cancer
-
12:24
the role of targeting dna repair with parp
-
1:41
faces of prostate cancer: dr. tomasz beer
-
4:59
what happens when your dna is damaged? - monica menesini
-
9:58
molecular imaging for prostate cancer
-
7:03
dna damage & repair
-
3:39
dna damage response
-
3:05
genetics in prostate cancer
-
0:57
tom beer, md, shares impressions of the titan study invesigating 1st line therapy in mcrpc patients
-
1:31
tackling disease progression whilst using parp inhibitors for prostate cancer
-
31:57
episode 1 - talking prostate cancer: homologous recombination repair gene mutation testing in met...
-
0:54
dr. oh on the importance of identifying dna damage repair mutations in prostate cancer
-
1:37
anis hamid, md, describes quality of life analysis' impact treatment of metastatic prostate cancer
-
1:01
multiparametric mri and prostate cancer: usanz
-
0:47
tom beer, md on the data presented at asco gu20 investigating atezolizumab and cabozantinib in mcrpc
-
1:02
where can parp inhibitors be used
-
1:33
the toparp-a trial